Product Information
FENOFIBRATE 54 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.0733 per EA under NDC 27241011603. Its NADAC has been published 414 times since Oct 31, 2018.
FDA first approved this application on Jul 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
54 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241011603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210138FDA Approved
7/23/2018
TE Code
AB
On Market Since
7/20/2018
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 54 MG TABLET has been published 414 times since Oct 31, 2018, and over the history we have for it it has declined 70.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0733 per EA |
|---|---|
| All-time high | $0.2641 (Jan 16, 2019) |
| All-time low | $0.0561 (Dec 17, 2025) |
| 52-week high | $0.0900 |
| 52-week low | $0.0561 |
| Median price | $0.1113 |
| Average price | $0.1374 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 414 |
| Tracking since | Oct 31, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fenofibrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fenofibrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 54 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 54 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.0733 per EA (NDC 27241011603), effective Sep 30, 2026.
How has the price of FENOFIBRATE 54 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 54 MG TABLET has declined 70.0%. It has been tracked across 414 weekly CMS publications since Oct 31, 2018.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 54 MG TABLET?
Since Oct 31, 2018, the NADAC for FENOFIBRATE 54 MG TABLET has ranged from a low of $0.0561 (Dec 17, 2025) to a high of $0.2641 (Jan 16, 2019), with a median of $0.1113 per EA.
Are there cheaper alternatives to FENOFIBRATE 54 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FENOFIBRATE 54 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENOFIBRATE 54 MG TABLET?
FENOFIBRATE 54 MG TABLET (NDC 27241011603) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.